 LOS ANGELES, June 15, 2021 PRNewswire -- NASDAQ: ENOB A promising cure for HIV is moving one step closer to FDA approval. The novel approach to treating HIV in humans using cell therapy, developed by Dr. Serhat Gumrukcu Dr. Serhat, Director of the Seraph Research Institute SRI, and his team, will move forward to the first stage of the approval process with the FDA a Pre-Investigational New Drug Pre-IND meeting. 